Cost-effectiveness of Maintenance Therapy Based on Molecular Classification Following Treatment of Primary Epithelial Ovarian Cancer in the United States

IMPORTANCE: There are large randomized clinical trials—SOLO-1 (Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy [December 2018]), PRIMA (A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer F...

Descripción completa

Detalles Bibliográficos
Autores principales: Penn, Courtney A., Wong, Melissa S., Walsh, Christine S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726632/
https://www.ncbi.nlm.nih.gov/pubmed/33295974
http://dx.doi.org/10.1001/jamanetworkopen.2020.28620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726632/
https://www.ncbi.nlm.nih.gov/pubmed/33295974
http://dx.doi.org/10.1001/jamanetworkopen.2020.28620

Ejemplares similares